(LEN-B) Lennar - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5260573028
LEN-B: Single-Family, Multifamily, Residential
Lennar Corporation (NYSE: LEN-B) is a leading U.S. homebuilder with operations spanning multiple regions, including Homebuilding East, Homebuilding Central, Homebuilding Texas, and Homebuilding West. The company also operates Financial Services, Multifamily, and Lennar Other segments. Its core business involves the construction and sale of single-family homes, including attached and detached properties, as well as land development for residential use. Additionally, Lennar engages in the development, construction, and management of multifamily rental properties. The company provides a range of ancillary services, such as residential mortgage financing, title insurance, and closing services, to streamline the homebuying process. It also originates and securitizes commercial mortgage loans and participates in fund investment activities. Lennar primarily caters to first-time buyers, move-up buyers, active adult communities, and luxury homebuyers. Founded in 1954, the company is headquartered in Miami, Florida, and has established itself as one of the largest homebuilders in the United States, with a strong focus on affordable and luxury housing across diverse demographics and geographies.
From a technical standpoint, LEN-B is currently trading below its 20-day (104.57), 50-day (111.63), and 200-day (137.99) moving averages, indicating a bearish trend. The ATR of 4.13 suggests moderate volatility. Over the next three months, the stock is likely to face resistance at the 50-day SMA level of 111.63, with potential support near the recent lows around 95.00. Fundamentally, Lennars P/E ratio of 7.69 reflects undervaluation relative to its earnings, while its forward P/E of 10.55 signals expectations of future growth. The P/B ratio of 1.23 indicates that the stock is fairly valued relative to its book value. With a P/S ratio of 0.82 and an RoE of 13.39, the company demonstrates strong profitability and efficient use of equity. However, rising interest rates and supply chain pressures may continue to impact margins and demand, presenting headwinds for the stock in the near term.
Additional Sources for LEN-B Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LEN-B Stock Overview
Market Cap in USD | 28,888m |
Sector | Consumer Cyclical |
Industry | Residential Construction |
GiC Sub-Industry | Homebuilding |
IPO / Inception | 2003-04-23 |
LEN-B Stock Ratings
Growth Rating | 55.2 |
Fundamental | 51.5 |
Dividend Rating | 68.9 |
Rel. Strength | -18.2 |
Analysts | - |
Fair Price Momentum | 103.47 USD |
Fair Price DCF | 1080.37 USD |
LEN-B Dividends
Dividend Yield 12m | 1.63% |
Yield on Cost 5y | 5.57% |
Annual Growth 5y | 26.19% |
Payout Consistency | 94.3% |
LEN-B Growth Ratios
Growth Correlation 3m | -87.3% |
Growth Correlation 12m | -62.4% |
Growth Correlation 5y | 85.8% |
CAGR 5y | 24.31% |
CAGR/Max DD 5y | 0.56 |
Sharpe Ratio 12m | -0.10 |
Alpha | -32.03 |
Beta | 0.535 |
Volatility | 36.54% |
Current Volume | 63.8k |
Average Volume 20d | 50.5k |
As of May 09, 2025, the stock is trading at USD 104.00 with a total of 63,794 shares traded.
Over the past week, the price has changed by +1.33%, over one month by +6.85%, over three months by -11.71% and over the past year by -24.38%.
Partly, yes. Based on ValueRay Fundamental Analyses, Lennar (NYSE:LEN-B) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.49 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LEN-B as of May 2025 is 103.47. This means that LEN-B is currently overvalued and has a potential downside of -0.51%.
Lennar has no consensus analysts rating.
According to ValueRays Forecast Model, LEN-B Lennar will be worth about 113.2 in May 2026. The stock is currently trading at 104.00. This means that the stock has a potential upside of +8.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 113.2 | 8.9% |